From the outset Terna acquired all the necessary protective equipment (FFP2 masks, latex gloves, protective coveralls) to guarantee continuity of the control rooms by ensuring the presence of personnel under adequate safety conditions for at least 10 days, conditional to the critical procurement issues of healthcare facilities. Periodic, thorough sanitisation of sites and construction sites is now fully operational.
Already from 26 February 2020, at the offices in Northern Italy, smart working was introduced for 100% of office personnel, and was then gradually extended to cover, from Friday, 13 March 100% of the company personnel not involved in direct operations, except for some corporate structures providing essential services or unavoidable service requirements.
At this time we are progressively and safely returning to working in the office again with an average daily share of administrative employees on the premises equal to 40% and the remaining 60% working remotely (data updated to the third quarter of 2021).
With a view to improving work-life balance and thanks to the adoption of a hybrid model, Terna has expanded the offer of alternative physical spaces to use instead of private ones by inaugurating two Smart Hub-Working locations in Rome, which can be booked through the company Intranet or directly from the dedicated app.
Terna launched the internal Sicuri Insieme (“Safe Together”) campaign which, in addition to keeping the focus on prevention through awareness and information initiatives, provides for the possibility of undergoing a molecular swab test on site, once a month and free of charge. As of September 2021, employees can also book a serological test on site to check the level of antibodies developed after their vaccination cycle. During the third quarter of 2021, the first 650 serological tests were carried out in the Rome offices. In addition, the 2021 flu vaccine campaign for Terna employees and their adult family members was launched in November.
Biosafety Trust Certification
In July, the effectiveness of the measures adopted by Terna to prevent and mitigate the spread of infections caused by biological agents, in order to protect human health, resulted in our Rome headquarters receiving certification of its Management System for the Prevention and Control of Infections, in accordance with the Biosafety Trust Certification standards published by RINA.
The certification develops a set of reference best practices to minimise the risks of spreading epidemics in public and private areas where people gather and is based on the systemic approach of the ISO standards on management systems.